期刊文献+
共找到463篇文章
< 1 2 24 >
每页显示 20 50 100
Effects of Mitochondrial Dysfunction via AMPK/PGC-1α Signal Pathway on Pathogenic Mechanism of Diabetic Peripheral Neuropathy and the Protective Effects of Chinese Medicine 被引量:21
1
作者 ZHANG Qian LIANG Xiao-chun 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2019年第5期386-394,共9页
Diabetic peripheral neuropathy(DPN) is a progressive neurodegenerative disease of peripheral nervous system with high energy requirement. The adenosine monophosphate-activated protein kinase(AMPK)/peroxisome prolifera... Diabetic peripheral neuropathy(DPN) is a progressive neurodegenerative disease of peripheral nervous system with high energy requirement. The adenosine monophosphate-activated protein kinase(AMPK)/peroxisome proliferator-activated receptor-γ coactivator 1α(PGC-1α) axis plays a key role in regulating mitochondrial energy metabolism. Increasing preclinical evidences have shown that inhibition of AMPK/PGC-1α pathway leading to mitochondrial dysfunction in neurons or Schwann cells contributes to neuron apoptosis, distal axonopathy and nerve demyelination in DPN. Some Chinese medicine formulae or extracts from herbs may have potential neuroprotective effects on DPN via activating AMPK/PGC-1α pathway and improving mitochondrial function. 展开更多
关键词 monophosphate-activated protein kinase PEROXISOME proliferator-activated receptor-γ coactivator SIRTUINS diabetic peripheral NEUROPATHY Chinese medicine
原文传递
核辅激活因子PGC-1表达的分子调控机制 被引量:13
2
作者 孙亮 朱小泉 +2 位作者 王沥 金锋 杨泽 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2005年第4期431-439,共9页
过氧化物酶体增殖物激活受体γ辅激活因子1(peroxisomeproliferatoractivatedreceptorγcoactivator1,PGC1)是一种多功能的转录调节因子,其广泛参与线粒体生物合成及能量代谢、糖脂代谢等多条代谢通路调节的特点预示PGC1在现代医学中可... 过氧化物酶体增殖物激活受体γ辅激活因子1(peroxisomeproliferatoractivatedreceptorγcoactivator1,PGC1)是一种多功能的转录调节因子,其广泛参与线粒体生物合成及能量代谢、糖脂代谢等多条代谢通路调节的特点预示PGC1在现代医学中可能极具应用潜力.其表达量的降低或上调,对于生物体的代谢调节均具有相当的生理或病理意义.本文从转录水平和翻译后水平综述了调控PGC1表达的具体分子机制,重点对转录水平调控PGC1表达的3条信号通路的研究进展及生物学意义进行了探讨.对PGC1表达的分子调控机制中所蕴含的药物靶点应用前景进行了初步展望. 展开更多
关键词 PGC-1 辅激活因子 转录调节 药物分子靶点
下载PDF
The X-linked mental retardation gene PHF8 is a histone demethylase involved in neuronal differentiation 被引量:16
3
作者 Jihui Qiu Guang Shi +5 位作者 Yuanhui Jia Jing Li Meng Wu Jiwen Li Shuo Dong Jiemin Wong 《Cell Research》 SCIE CAS CSCD 2010年第8期908-918,共11页
Recent studies have identified mutations in PHF8, an X-linked gene encoding a JmjC domain-containing protein, as a causal factor for X-linked mental retardation (XLMR) and cleft lip/cleft palate. However, the underl... Recent studies have identified mutations in PHF8, an X-linked gene encoding a JmjC domain-containing protein, as a causal factor for X-linked mental retardation (XLMR) and cleft lip/cleft palate. However, the underlying mechanism is unknown. Here we show that PHF8 is a histone demethylase and coactivator for retinoic acid receptor (RAR). Although activities for both H3K4me3/2/1 and H3K9me2/1 demethylation were detected in cellularbased assays, reeombinant PHF8 exhibited only H3K9me2/1 demethylase activity in vitro, suggesting that PHF8 is an H3K9me2/1 demethylase whose specificity may be modulated in vivo. Importantly, a mutant PHF8 (phenylalanine at position 279 to serine) identified in the XLMR patients is defective in enzymatie activity, indicating that the loss of histone demethylase activity is causally linked with the onset of disease. In addition, we show that PHF8 binds specifically to H3K4me3/2 peptides via an N-terminal PHD finger domain. Consistent with a role for PHF8 in neuronal differentiation, knockdown of PHF8 in mouse embryonic carcinoma P19 cells impairs RA-induced neuronal differentiation, whereas overexpression of the wild-type but not the F279S mutant PHF8 drives PI9 cells toward neuronal differentiation. Furthermore, we show that PHF8 interacts with RAR~ and functions as a coactivator for RARa. Taken together, our results suggest that histone methylation modulated by PHF8 plays a critical role in neuronal differentiation. 展开更多
关键词 PHF8 histone demethylase coactivator XLMR neuronal differentiation
下载PDF
核辅激活因子PGC-1作用分子机制的研究进展 被引量:12
4
作者 孙亮 金锋 +1 位作者 王沥 杨泽 《遗传》 CAS CSCD 北大核心 2005年第2期302-308,共7页
过氧化物酶体增殖物激活受体γ辅激活因子 1(peroxisome proliferator activated receptor γcoactivator 1,PGC 1)通过结合下游转录因子广泛参与线粒体生物合成、肝糖异生等重要代谢通路调节,对于维持生物体能量动态平衡有重要生理意... 过氧化物酶体增殖物激活受体γ辅激活因子 1(peroxisome proliferator activated receptor γcoactivator 1,PGC 1)通过结合下游转录因子广泛参与线粒体生物合成、肝糖异生等重要代谢通路调节,对于维持生物体能量动态平衡有重要生理意义。文章着重综述了基于PGC 1基因及蛋白结构基础的分子对接、组蛋白乙酰化、RNA加工等分子机制的研究现状,并初步探讨了其与代谢综合征发生的应用展望。过氧化物酶体增殖物激活受体γ辅激活因子 1(peroxisome proliferator activated receptor γcoactivator 1,PGC 1)通过结合下游转录因子广泛参与线粒体生物合成、肝糖异生等重要代谢通路调节,对于维持生物体能量动态平衡有重要生理意义。文章着重综述了基于PGC 1基因及蛋白结构基础的分子对接、组蛋白乙酰化、RNA加工等分子机制的研究现状,并初步探讨了其与代谢综合征发生的应用展望。 展开更多
关键词 PGC-1 辅激活因子 转录调节 组蛋白乙酰化 P38 MAPK
下载PDF
Effect of the Shensong Yangxin Capsule on Energy Metabolism in Angiotensin II-lnduced Cardiac Hypertrophy 被引量:11
5
作者 Bei-Lei Liu Mian Cheng +6 位作者 Shan Hu Shun Wang Le Wang Zheng-Qing Hu Cong-Xin Huang Hong Jiang Gang Wu 《Chinese Medical Journal》 SCIE CAS CSCD 2018年第19期2287-2296,共10页
Background:Shensong Yangxin Capsule (SSYX),traditional Chinese medicine,has been used to treat arrhythmias,angina,cardiac remodeling,cardiac fibrosis,and so on,but its effect on cardiac energy metabolism is still n... Background:Shensong Yangxin Capsule (SSYX),traditional Chinese medicine,has been used to treat arrhythmias,angina,cardiac remodeling,cardiac fibrosis,and so on,but its effect on cardiac energy metabolism is still not clear.The objective of this study was to investigate the effects of SSYX on myocardium energy metabolism in angiotensin (Ang) Ⅱ-induced cardiac hypertrophy.Methods:We used 2 μl (10-6 mol/L) AngⅡ to treat neonatal rat cardiomyocytes (NRCMs) for 48 h.Myocardial α-ac tinin staining showed that the myocardial cell volume increased.Expression of the cardiac hypertrophic marker-brain natriuretic peptide (BNP) messenger RNA (mRNA) also increased by real-time polymerase chain reaction (PCR).Therefore,it can be assumed that the model of hypertrophic cardiomyocytes was successfully constructed.Then,NRCMs were treated with 1 μl of different concentrations of SSYX (0.25,0.5,and 1.0 μg/ml) for another 24 h.To explore the time-depend effect of SSYX on energy metabolism,0.5 μg/ml SSYX was added into cells for 0,6,12,24,and 48 h.Mitochondria was assessed by MitoTracker staining and confocal microscopy.mRNA and protein expression of mitochondrial biogenesis-related genes-Peroxisome proliferator-activated receptor-γ coactivator-1 α (PGC-1 α),energy balance key factor -adenosine monophosphate-activated protein kinase (AMPK),fatty acids oxidation factor-camitine palmitoyltransferase-1 (CPT-1),and glucose oxidation factor-glucose transporter-4 (GLUT-4) were measured by PCR and Western blotting analysis.Results:With the increase in the concentration of SSYX (from 0.25 to 1.0 μg/ml),an increased mitochondrial density in Angll-induced cardiomyocytes was found compared to that of those treated with Angll only (0.25 μg/ml,18.3300 ± 0.8895 vs.24.4900 ± 0.9041,t =10.240,P 〈 0.0001;0.5 μg/ml,18.3300 ± 0.8895 vs.25.9800 ± 0.8187,t =12.710,P 〈 0.0001;and 1.0 μg/ml,18.3300 ± 0.8895 vs.24.2900 ± 1.3120,t =9.902,P 〈 0.0001;n =5 per dosage group) 展开更多
关键词 AMP-Activated Protein Kinase Cardiac Hypertrophy Energy Metabolism Peroxisome Proliferator-Activated ReceptorGamma coactivator- 1 Alpha Shensong Yangxin Capsule
原文传递
电针联合天麻素对阿尔茨海默病大鼠海马CA 1区沉默信息调节因子2同源蛋白1和过氧化物酶体增殖物激活受体γ辅激活子1 ɑ表达的影响 被引量:13
6
作者 黄锐 吴锋 +3 位作者 赵健 李怀斌 丁见 熊克仁 《针刺研究》 CAS CSCD 北大核心 2018年第3期140-145,共6页
目的:探讨电针联合天麻素治疗阿尔茨海默病(AD)的作用机制。方法:SD大鼠随机分为正常组、假手术组、模型组、电针组、天麻素组和针药联合组,每组10只。腹腔注射D-半乳糖联合双侧海马注射β淀粉样蛋白1-40制备AD大鼠模型。电针组和针药... 目的:探讨电针联合天麻素治疗阿尔茨海默病(AD)的作用机制。方法:SD大鼠随机分为正常组、假手术组、模型组、电针组、天麻素组和针药联合组,每组10只。腹腔注射D-半乳糖联合双侧海马注射β淀粉样蛋白1-40制备AD大鼠模型。电针组和针药联合组给予"百会""大椎"、双侧"足三里"穴电针刺激,每次30min,1次/d,连续4周;天麻素组和针药联合组腹腔注射天麻素注射液,每日1次,连续4周。Morris水迷宫检测各组大鼠学习记忆能力;尼氏染色观察海马CA 1区神经元形态;免疫组织化学法检测各组大鼠海马CA 1区沉默信息调节因子2同源蛋白1(SIRT 1)和过氧化物酶体增殖物激活受体γ辅激活子(PGC-1ɑ)的表达。结果:Morris水迷宫结果显示,与正常组及假手术组比较,模型组大鼠逃避潜伏期延长(P<0.05),平台象限停留时间百分比、穿台次数降低(P<0.05);与模型组比较,电针与天麻素及联合使用均可降低AD大鼠的逃避潜伏期(P<0.05),提高平台象限停留时间百分比(P<0.05),增加穿台次数(P<0.05);针药联合组的效果优于电针组及天麻素组(P<0.05)。尼氏染色结果显示,与正常组及假手术组比较,模型组大鼠海马CA 1区神经元数量减少,排列紊乱;各治疗组CA 1区神经元数量较模型组明显增多,排列规则。与正常组及假手术组比较,模型组大鼠海马CA 1区SIRT 1和PGC-1ɑ阳性表达水平降低(P<0.05);与模型组比较,电针组和天麻素组CA 1区SIRT 1和PGC-1ɑ阳性表达水平升高(P<0.05);针药联合组的表达水平高于电针组和天麻素组(P<0.05)。结论:电针与天麻素均能够改善AD大鼠的学习记忆能力,且电针联合天麻素的效果更为显著,提示其可能通过上调海马SIRT 1和PGC-1ɑ蛋白的表达,发挥对AD大鼠神经元的保护作用。 展开更多
关键词 电针 天麻素 阿尔茨海默病 沉默信息调节因子2同源蛋白1 过氧化物酶体增殖物激活受体γ辅激活子 海马CA 1区 学习记忆能力
原文传递
Natural products,PGC-1α,and Duchenne muscular dystrophy 被引量:12
7
作者 Ipek Suntar Antoni Sureda +13 位作者 Tarun Belwal Ana Sanches Silva Rosa Anna Vacca Devesh Tewari Eduardo Sobarzo-Sánchez Seyed Fazel Nabavi Samira Shirooie Ahmad Reza Dehpour Suowen Xu Bahman Yousefi Maryam Majidinia Maria Daglia Giuseppe D’Antona Seyed Mohammad Nabavi 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2020年第5期734-745,共12页
Peroxisome proliferator-activated receptorγ(PPARγ)is a transcriptional coactivator that binds to a diverse range of transcription factors.PPARγcoactivator 1(PGC-1)coactivators possess an extensive range of biologic... Peroxisome proliferator-activated receptorγ(PPARγ)is a transcriptional coactivator that binds to a diverse range of transcription factors.PPARγcoactivator 1(PGC-1)coactivators possess an extensive range of biological effects in different tissues,and play a key part in the regulation of the oxidative metabolism,consequently modulating the production of reactive oxygen species,autophagy,and mitochondrial biogenesis.Owing to these findings,a large body of studies,aiming to establish the role of PGC-1 in the neuromuscular system,has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases.Among these,some evidence has shown that various signaling pathways linked to PGC-1αare deregulated in muscular dystrophy,leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species(ROS)production.In the light of these results,any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies.PGC-1αis influenced by different patho-physiological/pharmacological stimuli.Natural products have been reported to display modulatory effects on PPARγactivation with fewer side effects in comparison to synthetic drugs.Taken together,this review summarizes the current knowledge on Duchenne muscular dystrophy,focusing on the potential effects of natural compounds,acting as regulators of PGC-1α. 展开更多
关键词 Muscular dystrophy Natural product Peroxisome proliferator-activated receptor Y coactivator la PPARγactivation Reactive oxygen species Mitochondrial oxidative phosphorylation
原文传递
Micro RNA-124 slows down the progression of Huntington's disease by promoting neurogenesis in the striatum 被引量:8
8
作者 Tian Liu Wooseok Im +1 位作者 Inhee Mook-Jung Manho Kim 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第5期786-791,共6页
MicroRNA-124 contributes to neurogenesis through regulating its targets, but its expression both in the brain of Huntington's disease mouse models and patients is decreased. However, the effects of microRNA-124 on th... MicroRNA-124 contributes to neurogenesis through regulating its targets, but its expression both in the brain of Huntington's disease mouse models and patients is decreased. However, the effects of microRNA-124 on the progression of Huntington's disease have not been reported. Results from this study showed that microRNA-124 increased the latency to fall for each R6/2 Hunting- ton's disease transgenic mouse in the rotarod test. 5-Bromo-2'-deoxyuridine (BrdU) staining of the striatum shows an increase in neurogenesis. In addition, brain-derived neurotrophic factor and peroxisome proliferator-activated receptor gamma coactivator 1-alpha protein levels in the striatum were increased and SRY-related HMG box transcription factor 9 protein level was de- creased. These findings suggest that microRNA-124 slows down the progression of Huntington's disease possibly through its important role in neuronal differentiation and survival. 展开更多
关键词 nerve regeneration microRNA-124 NEUROGENESIS neuronal survival Huntington'sdisease SRY-related HMG box transcription factor 9 brain-derived neurotrophic factor peroxisomeproliferator-activated receptor gamma coactivator 1-alpha mutant huntingtin
下载PDF
Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways:The therapeutic implications 被引量:10
9
作者 Tianai Sun Jen-Tsan Chi 《Genes & Diseases》 SCIE 2021年第3期241-249,共9页
Ferroptosis is a novel form of iron-dependent cell death characterized by lipid per-oxidation.While the importance and disease relevance of ferroptosis is gaining recognition,much remains unknown about various genetic... Ferroptosis is a novel form of iron-dependent cell death characterized by lipid per-oxidation.While the importance and disease relevance of ferroptosis is gaining recognition,much remains unknown about various genetic and non-genetic determinants of ferroptosis.Hippo signaling pathway is an evolutionarily conserved pathway that responds to various envi-ronmental cues and controls organ size,cell proliferation,death,and self-renewal capacity.In cancer biology,Hippo pathway is a potent tumor suppressing mechanism and its dysregulation contributes to apoptosis evasion,cancer development,metastasis,and treatment resistance.Hippo dysregulation leads to aberrant activation of YAP and TAZ,the two major transcription co-activators of TEADs,that induce the expression of genes triggering tumor-promoting pheno-types,including enhanced cell proliferation,self-renewal and apoptosis inhibition.The Hippo pathway is regulated by the cell-cell contact and cellular density/confluence.Recently,fer-roptosis has also been found being regulated by the cellular contact and density.The YAP/TAZ activation under low density,while confers apoptosis resistance,renders cancer cells sensitivity to ferroptosis.These findings establish YAP/TAZ and Hippo pathways as novel deter-minants of ferroptosis.Therefore,inducing ferroptosis may have therapeutic potential for YAP/TAZ-activated chemo-resistant and metastatic tumor cells.Reciprocally,various YAP/TAZ-targeting treatments under clinical development may confer ferroptosis resistance,limiting the therapeutic efficacy. 展开更多
关键词 APOPTOSIS Ferroptosis Hippo pathway Transcriptional coactivator with PDZ-binding motif(TAZ) Yes-associated protein 1(YAP1)
原文传递
核受体辅活化子PNRC与孤儿核受体SF1相互作用位点的鉴定 被引量:6
10
作者 陈彬 陈敏 +2 位作者 陈健 李渝萍 周度金 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2002年第1期38-43,共6页
为了阐明核受体辅活化子 (proline richnuclearreceptorcoactivatorprotein ,PNRC)在孤儿核受体类固醇生成因子 1(steroidogenicfactor1,SF1)基因表达调控中的作用 ,采用酵母双杂合分析、缺失突变技术和瞬时转染等研究方法鉴定了PNRC与... 为了阐明核受体辅活化子 (proline richnuclearreceptorcoactivatorprotein ,PNRC)在孤儿核受体类固醇生成因子 1(steroidogenicfactor1,SF1)基因表达调控中的作用 ,采用酵母双杂合分析、缺失突变技术和瞬时转染等研究方法鉴定了PNRC与SF1的相互作用位点 .结果显示 ,PNRC中氨基酸 2 78~ 30 0区域是与SF1相互作用的位点 .该区域富含脯氨酸 ,其中有 1个SH3结合模体 (motif) ,单独的SH3模体不足以与SF1产生有效的相互作用 .瞬时转染分析表明 ,PNRC 2 70 32 7对野生型PNRC的辅激活功能具有负显性抑制效应 .研究结果表明 ,含SH3结合模体的PNRC 2 78 30 展开更多
关键词 核受体辅活化子 PNRC 类固醇生成因子1 相互作用位点 孤儿核受体SF1
下载PDF
Mechanism of acupuncture in attenuating cerebral ischaemia-reperfusion injury based on nuclear receptor coactivator 4 mediated ferritinophagy 被引量:1
11
作者 ZHANG Xinchang HUANG Zheng +3 位作者 HUANG Peiyan YANG Mengning ZHANG Zhihui NI Guangxia 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2024年第2期345-352,共8页
OBJECTIVE:To explore the effect of acupuncture treatment on cerebral ischaemia-reperfusion injury(CIRI)and reveal the underlying mechanism of the effect based on nuclear receptor coactivator 4(NCOA4)mediated ferritino... OBJECTIVE:To explore the effect of acupuncture treatment on cerebral ischaemia-reperfusion injury(CIRI)and reveal the underlying mechanism of the effect based on nuclear receptor coactivator 4(NCOA4)mediated ferritinophagy.METHODS:Sprague-Dawley male rats were divided into four groups:the sham group,model group,acupuncture group,and sham acupuncture group.After 2 h of middle cerebral artery occlusion(MCAO),reperfusion was performed for 24 h to induce CIRI.The rats were treated with acupuncture at the Neiguan(PC6)and Shuigou(GV26)acupoints.Their neurological function was evaluated by taking their Bederson scores at 2 h after ischaemia and 24 h after reperfusion.Triphenyltetrazolium chloride staining was applied to assess the cerebral infarct volume at 24 h after reperfusion.The malondialdehyde(MDA)and ferrous iron(Fe^(2+))levels were observed after 24 h of reperfusion using an assay kit.Western blotting was performed to detect the expression of NCOA4 and ferritin heavy chain 1(FTH1)at 24 h after reperfusion.Moreover,the colocalization of ferritin with neurons,NCOA4 with microtubule-associated protein 1 light chain 3(LC3),and NCOA4 with ferritin was visualized using immunofluorescence staining.RESULTS:Acupuncture significantly improved neurological function and decreased cerebral infarct volume in the acupuncture group.Following CIRI,the expression of NCOA4,LC3 and FTH1 was increased,which enhanced ferritinophagy and induced an inappropriate accumulation of Fe^(2+)and MDA in the ischaemic brain.However,acupuncture dramatically downregulated the expression of NCOA4,LC3 and FTH1,inhibited the overactivation of ferritinophagy,and decreased the levels of MDA and Fe^(2+).CONCLUSIONS:Acupuncture can inhibit NCOA4-mediated ferritinophagy and protect neurons against CIRI in a rat model. 展开更多
关键词 ACUPUNCTURE ferritinophagy ferroptosis FERRITIN nuclear receptor coactivator 4 cerebral ischaemia-reperfusion injury
原文传递
核受体及其转录活化机制研究的新突破——辅活化子和辅阻遏子 被引量:4
12
作者 穆小民 刘以训 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 1998年第3期222-226,共5页
核受体是一类配体依赖的转录因子,它们之间有相似的结构,在进化上来源于同一前体,它们和基础转录因子有直接的联系,与配体结合后,作用于其目标基因的特定应答元件上,从而活化特定基因的转录.核受体介导的转录活化需要有辅活化子... 核受体是一类配体依赖的转录因子,它们之间有相似的结构,在进化上来源于同一前体,它们和基础转录因子有直接的联系,与配体结合后,作用于其目标基因的特定应答元件上,从而活化特定基因的转录.核受体介导的转录活化需要有辅活化子(coactivator)和辅阻遏子(corepresor)的参与,这些辅活化子和辅阻遏子是有效的转录所必需的.它们能和核受体特异结合,并在核受体和基础转录因子之间发挥中介作用.目前发现普遍存在并在转录过程中具有重要作用的辅活化子有CBP/P300和SRC1等,辅阻遏子有SMRT等. 展开更多
关键词 核受体 转录因子 辅活化子 辅阻遏子
下载PDF
c-Jun/激活蛋白-1活性调节研究进展 被引量:6
13
作者 张令强 贺福初 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2002年第6期872-876,共5页
转录因子激活蛋白 1(AP 1)对细胞增殖、细胞存活与细胞凋亡等重要生理过程具有调控作用 ,其核心组成成分是c Jun .c Jun活性从转录调控、翻译后调控 (主要是磷酸化调节 )和相互作用蛋白质调节等三个水平受到正负向调控 .其分子内 8个位... 转录因子激活蛋白 1(AP 1)对细胞增殖、细胞存活与细胞凋亡等重要生理过程具有调控作用 ,其核心组成成分是c Jun .c Jun活性从转录调控、翻译后调控 (主要是磷酸化调节 )和相互作用蛋白质调节等三个水平受到正负向调控 .其分子内 8个位点可被JNK1、GSK3、CKII、Abl等激酶磷酸化 .通过N端的转录激活结构域和C端的碱性亮氨酸拉链区 ,c Jun可与bZIP类转录因子、辅助激活因子和其他一些蛋白质直接相互作用而被调控 .另外一些分子可通过CBP、JAB1等重要辅助激活因子的介导间接调控AP 1的活性 ,共同构成AP 展开更多
关键词 C-JUN 激活蛋白-1 活性调节 研究进展 蛋白质磷酸 蛋白质-蛋白质相互作用 辅助激活因子
下载PDF
Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma
14
作者 Li Peng Yanyi Jiang +13 位作者 Hengxing Chen Yongqiang Wang Qiusheng Lan Shuiqin Chen Zhanwang Huang Jingyuan Zhang Duanqing Tian Yuntan Qiu Diankui Cai Jiangyun Peng Daning Lu Xiaoqing Yuan Xianzhu Yang Dong Yin 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2024年第5期2119-2136,共18页
Transcriptional dysregulation of genes is a hallmark of tumors and can serve as targets for cancer drug development.However,it is extremely challenging to develop small-molecule inhibitors to target abnormally express... Transcriptional dysregulation of genes is a hallmark of tumors and can serve as targets for cancer drug development.However,it is extremely challenging to develop small-molecule inhibitors to target abnormally expressed transcription factors(TFs)except for the nuclear receptor family of TFs.Little is known about the interaction between TFs and transcription cofactors in gastroesophageal adenocarcinoma(GEA)or the therapeutic effects of targeting TF and transcription cofactor complexes.In this study,we found that ETS homologous factor(EHF)expression is promoted by a core transcriptional regulatory circuitry(CRC),specifically ELF3-KLF5-GATA6,and interference with its expression suppressed the malignant biological behavior of GEA cells.Importantly,we identified Ajuba LIM protein(AJUBA)as a new coactivator of EHF that cooperatively orchestrates transcriptional network activity in GEA.Furthermore,we identified KRAS signaling as a common pathway downstream of EHF and AJUBA.Applicably,dual targeting of EHF and AJUBA by lipid nanoparticles cooperatively attenuated the malignant biological behaviors of GEA in vitro and in vivo.In conclusion,EHF is upregulated by the CRC and promotes GEA malignancy by interacting with AJUBA through the KRAS pathway.Targeting of both EHF and its coactivator AJUBA through lipid nanoparticles is a novel potential therapeutic strategy. 展开更多
关键词 EHF AJUBA KRAS pathway Enhancer Core transcriptional regulatory circuitry Gastroesophageal adenocarcinoma Gastric adenocarcinoma Esophageal adenocarcinoma Transcription factor coactivator Lipid nanoparticles
原文传递
Nuclear receptor coactivator 6 is a critical regulator of NLRP3 inflammasome activation and gouty arthritis
15
作者 Kang-Gu Lee Bong-Ki Hong +4 位作者 Saseong Lee Naeun Lee Seung-Whan Kim Donghyun Kim Wan-Uk Kim 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2024年第3期227-244,共18页
Transcriptional coactivators regulate the rate of gene expression in the nucleus.Nuclear receptor coactivator 6(NCOA6),a coactivator,has been implicated in embryonic development,metabolism,and cancer pathogenesis,but ... Transcriptional coactivators regulate the rate of gene expression in the nucleus.Nuclear receptor coactivator 6(NCOA6),a coactivator,has been implicated in embryonic development,metabolism,and cancer pathogenesis,but its role in innate immunity and inflammatory diseases remains unclear.Here,we demonstrated that NCOA6 was expressed in monocytes and macrophages and that its level was increased under proinflammatory conditions.Unexpectedly,nuclear NCOA6 was found to translocate to the cytoplasm in activated monocytes and then become incorporated into the inflammasome with NLRP3 and ASC,forming cytoplasmic specks.Mechanistically,NCOA6 associated with the ATP hydrolysis motifs in the NACHT domain of NLRP3,promoting the oligomerization of NLRP3 and ASC and thereby instigating the production of IL-1βand active caspase-1.Of note,Ncoa6 deficiency markedly inhibited NLRP3 hyperactivation caused by the Nlrp3^(R258W) gain-of-function mutation in macrophages.Genetic ablation of Ncoa6 substantially attenuated the severity of two NLRP3-dependent diseases,folic-induced acute tubular necrosis and crystal-induced arthritis,in mice.Consistent with these findings,NCOA6 was highly expressed in macrophages derived from gout patients,and NCOA6-positive macrophages were significantly enriched in gout macrophages according to the transcriptome profiling results.Conclusively,NCOA6 is a critical regulator of NLRP3 inflammasome activation and is therefore a promising target for NLRP3-dependent diseases,including gout. 展开更多
关键词 Nuclear receptor coactivator 6 Nuclear-to-cytoplasmic translocation NLRP3 inflammasome NACHT domain Gouty arthritis
原文传递
Inhibition of autophagy rescues HT22 hippocampal neurons from erastin-induced ferroptosis 被引量:2
16
作者 Nora Hanke Abdelhaq Rami 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第7期1548-1552,共5页
Ferroptosis is a regulated form of cell death which is considered an oxidative iron-dependent process.The lipid hydroperoxidase glutathione peroxidase 4 prevents the iron(Fe2+)-dependent formation of toxic lipid react... Ferroptosis is a regulated form of cell death which is considered an oxidative iron-dependent process.The lipid hydroperoxidase glutathione peroxidase 4 prevents the iron(Fe2+)-dependent formation of toxic lipid reactive oxygen species.While emerging evidence indicates that inhibition of glutathione peroxidase 4 as a hallmark of ferroptosis in many cancer cell lines,the involvement of this biochemical pathway in neuronal death remains largely unclear.Here,we investigate,first whether the ferroptosis key players are involved in the neuronal cell death induced by erastin.The second objective was to examine whether there is a cross talk between ferroptosis and autophagy.The third main was to address neuron response to erastin,with a special focus on ferritin and nuclear receptor coactivator 4-mediated ferritinophagy.To test this in neurons,erastin(0.5-8μM)was applied to hippocampal HT22 neurons for 16 hours.In addition,cells were cultured with the autophagy inhibitor,3-methyladenin(10 mM)and/or ferroptosis inhibitors,ferrostatin 1(10-20μM)or deferoxamine(10-200μM)before exposure to erastin.In this study,we demonstrated by immunofluorescence and western blot analysis,that erastin downregulates dramatically the expression of glutathione peroxidase 4,the sodium-independent cystine-glutamate antiporter and nuclear receptor coactivator 4.The protein levels of ferritin and mitochondrial ferritin in HT22 hippocampal neurons did not remarkably change following erastin treatment.In addition,we demonstrated that not only the ferroptosis inhibitor,ferrostatin1/deferoxamine abrogated the ferroptotic cell death induced by erastin in hippocampal HT22 neurons,but also the potent autophagy inhibitor,3-methyladenin.We conclude that(1)erastin-induced ferroptosis in hippocampal HT22 neurons,despite reduced nuclear receptor coactivator 4 levels,(2)that either nuclear receptor coactivator 4-mediated ferritinophagy does not occur or is of secondary importance in this model,(3)that ferroptosis seems to share some features of the autoph 展开更多
关键词 erastin FERRITIN ferritinophagy ferroptosis glutathione peroxidase 4 HT22 neurons nuclear receptor coactivator 4
下载PDF
Estrogen Receptor α(ERα) Target Gene LRP16 Interacts with ERα and Enhances Receptor's Transcriptional Activity 被引量:1
17
作者 韩为东 赵亚力 +3 位作者 吴志强 孟元光 臧丽 母义明 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2007年第4期233-237,共5页
Objective:It has been shown that LRP16 is an estrogen-induced gene through its receptor α(ERα). Although there is evidence demonstrating that inhibition of LRP16 gene expression in MCF-7 human breast cancer cells... Objective:It has been shown that LRP16 is an estrogen-induced gene through its receptor α(ERα). Although there is evidence demonstrating that inhibition of LRP16 gene expression in MCF-7 human breast cancer cells partially attenuates its estrogen-responsiveness, the underlying molecular mechanism is still unclear. Here, the effect of LRP16 expression on the ERα signaling transduction was investigated. Methods: Cotransfection assays were used to measure the effect of LRP16 on ERα-mediated transcriptional activity. GST-pulldown and immunoprecipitation (ColP) assays were employed to investigate the physical interaction of LRP16 and ERα. The mammalian two-hybrid method was used to map the functional interaction region. Results: the results of cotransfection assays demonstrated that the transcriptional activities of ERα were enhanced in α LRP16 dose-dependent manner in MCF-7 in the presence of estrogen, however, it was abolished in the absence of E2 in MCF-7 cells. The physical interaction of LRP16 and ERα proteins was confirmed by GST-pulldown in vitro and ColP in vivo assays, which was enhanced by E2 but not dependent on its presence. Furthermore, the results of the mammalian two-hybrid assays indicated that the binding region of ERα to LRP16 located at the A/B AF-1 functional domain and E2 stimulated the binding of LRP16 to the full-length ERα molecule but not to the A/B region alone. Conclusion: These results support a role for estrogenically regulated LRP16 as an ERα coactivator, providing a positive feedback regulatory loop for ERα signal transduction. Based on this function of LRP16, we propose that ERα-positive breast cancer patients with high expression of LRP16 might benefit from targeting LRP16 therapy. 展开更多
关键词 Estrogen receptorα LRP16 INTERACTION coactivator
下载PDF
Association between peroxisome proliferator-activated receptor-γ coactivator-1α gene polymorphisms and type 2 diabetes in southern Chinese population:role of altered interaction with myocyte enhancer factor 2C 被引量:3
18
作者 ZHANG Shao-ling LU Wen-sheng +4 位作者 YAN Li WU Mu-chao XU Ming-tong CHEN Li-hong CHENG Hua 《Chinese Medical Journal》 SCIE CAS CSCD 2007年第21期1878-1885,共8页
Background Some single nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor-y coactivator (PGC)-1α gene have been reported to be associated with type 2 diabetes in different populatio... Background Some single nucleotide polymorphisms (SNPs) in the peroxisome proliferator-activated receptor-y coactivator (PGC)-1α gene have been reported to be associated with type 2 diabetes in different populations, and studies on Chinese patients yielded controversial results. The objective of this case-control study was to explore the relationship between SNPs of PGC-1α and type 2 diabetes in the southern Chinese population and to determine whether the common variants: Gly482Ser and Thr394Thr, in the PGC-1α gene have any impacts on interaction with myocyte enhancer factor (MEF) 2C. Methods The SNPs in all exons of the PGC-1α gene was investigated in 50 type 2 diabetic patients using polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) and direct sequencing. Thereafter, 263 type 2 diabetic patients and 282 healthy controls were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). A bacterial two-hybrid system and site-directed mutagenesis were used to investigate whether Gly482Ser and Thr394Thr variants in the PGC-1α gene alter the interaction with MEF2C. Results Three frequent SNPs (Thr394Thr, Gly482Ser and Thr528Thr) were found in exons of the PGC-1α gene. Only the Gly482Ser variant had a different distribution between diabetic patients and healthy subjects, with the 482Ser allele more frequent in patients than in controls (40.1% vs 29.3%, P〈0.01). Even in controls, the 482Ser(A) carriers were more likely to have higher levels of total cholesterol and low-density lipoprotein cholesterol than the 482Gly(G) carriers. The 394A-482G-528A haplotype was associated with protection from diabetes, while the 394A-482A-528A was associated with the susceptibility to diabetes. The bacterial two-hybrid system and site-directed mutagenesis revealed that the 482Ser variant was less efficient than the 482Gly variant to interact with MEF2C, whereas the 394Thr (A) had a synergic effect on the interaction between 482 展开更多
关键词 peroxisome proliferator-activated receptor gamma coactivator 1 alpha type 2 diabetes myocyte enhancer factor 2C single nucleotide polymorphisms polymerase chain reaction
原文传递
Mitochondrial dysfunction in a rat model and the related risk of metabolic disorders 被引量:1
19
作者 LI Han HUANG Xiaomin +7 位作者 CAI Haiyang HEROK George HE Jing SU Yixun LI Weihong YI Chenju OLIVER Brian G CHEN Hui 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2023年第1期95-104,共10页
OBJECTIVE:To explore whether kidney Yang deficiency(KYD)is prone to metabolic disorders may be linked to impaired mitochondrial function in thermogenesis and metabolic tissues.METHODS:A rat model of KYD was used,which... OBJECTIVE:To explore whether kidney Yang deficiency(KYD)is prone to metabolic disorders may be linked to impaired mitochondrial function in thermogenesis and metabolic tissues.METHODS:A rat model of KYD was used,which was established using Sprague Dawley rat dams with warm preference subjected to herbal treatment that can improve kidney Yang.The human relevance was confirmed by reduced serum corticosterone levels,and increased preference for warm location.RESULTS:KYD Rats were underdeveloped.Adenosinetriphosphate(ATP)production was reduced in the brown fat,but increased in the muscle.However,oxidative phosphorylated complexes to generate ATP and mitochondrial biogenesis marker were reduced in both tissues.When the second insult of high-fat diet(HFD)was introduced,KYD rats gained less weight yet developed more severe lipid and glucose metabolic disorders.This may be driven by disregulated liver gluconeogenesis marker forkhead box protein O1 and lipid metabolic regulator cholesterol 7 alpha-hydroxylase.CONCLUSION:KYD rats exhibited reduced mitochondrial function in the brown fat,but were partially compensated by skeletal muscle,associated with the phenotype of warm preference and metabolic disorder,which was further exacerbated by additional HFD consumption.Future studies can focus on treatment targetting mitochondria function to reverse this phenotype. 展开更多
关键词 kidney Yang deficiency DNA mitochondrial adenosine triphosphate THERMOGENESIS peroxisome proliferator-activated receptor gamma coactivator 1-alpha
原文传递
Sirtuins Function as the Modulators in Aging-related Diseases in Common or Respectively 被引量:2
20
作者 Qi-Lin Wang Shang-Jing Guo 《Chinese Medical Journal》 SCIE CAS CSCD 2015年第12期1671-1678,共8页
INTRODUCTIONAccording to the demographics, the world population over 60 years will double from 605 million to 2 billion people between 2000 and 2050. Aging is a complex process in which the organism and its ability to... INTRODUCTIONAccording to the demographics, the world population over 60 years will double from 605 million to 2 billion people between 2000 and 2050. Aging is a complex process in which the organism and its ability to respond to external stresses become progressive decline. 展开更多
关键词 Aging-related Disease DEACETYLASE Hypoxia Inducible Factor-1α NAD+ Peroxisome Proliferator-activated Receptor-γ coactivator- SIRTUINS
原文传递
上一页 1 2 24 下一页 到第
使用帮助 返回顶部